Abstract:The pharmaceutical industry often depends on statistics to improve product quality, optimize the compositions, streamline operations, and conform to regulatory requirements. In Bio Equivalency investigations, Statistics plays an integral role in decision-making while demonstrating the similarity between the test and reference products. In this review, we explore how statistics play a crucial role in pharmaceutical product development. We start with examining experiments, where statistics help scientists find the best combinations of ingredients and manufacturing conditions. We explored different types of experiments, like factorial designs, Plackett-Burman designs, Box-Behnken designs, and Taguchi designs. While optimizing the formulations and process parameters, these methodologies assist researchers in making meaningful conclusions supported by statistical inference. The next sections include Response Surface Methodology (RSM) and Mixture Designs, which help in the development of drug formulations and the comprehension of complex responses. The development of pharmaceuticals is made simpler by these approaches. Then, we examine optimal designs like A-optimal, I-optimal, and D-optimal. A-optimal designs save resources, I-optimal designs focus on precise estimates, and D-optimal designs are great for screening and getting accurate results. These designs help scientists make decisions based on data. The starting point for demonstrating dissolution similarity between generic and reference products is the statistical approach. This paper examines the use of model-dependent techniques, such as zero-order, first-order, Higuchi, and Weibull models, and model-independent techniques such as F1, F2, Bootstrap, MSD, and PCA techniques, it analyzes important parameters and bounds that are essential for determining the dissolution similarity. In the field of biostatistics, we discuss how statistics ensures that generic drugs are safe and work just as efficiently as brand-name drugs. Both regulatory approval and patient safety rely on this. We briefly discuss statistical process control (SPC) in closing. SPC checks that drugs/drug products are consistently of quality using graphs and figures. It facilitates the production of consistently effective pharmaceuticals by organizations. Advanced statistical techniques, including data mining, machine learning, and artificial intelligence, are revolutionizing the pharmaceutical industry. These tools enhance drug discovery, optimize manufacturing processes, and pave the way for personalized medicine. As real-time monitoring and predictive analytics become integral, the future holds exciting possibilities for improving patient outcomes. This review shows how statistics are like a guiding tool in the pharmaceutical industry. Whether it's in the lab or in manufacturing, statistics play a big role in making sure patients get the best medicines possible.

Data-reduction problems in biopharmaceutics and pharmacokinetics

Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring

Checking distributional assumptions for pharmacokinetic summary statistics based on simulations with compartmental models

The Use of Population Pharmacokinetics in Drug Development

On modelling of bioavailability of drugs in terms of conservation laws

New Approaches to the Use of Pharmacokinetics in Toxicology and Drug Development

Statistical considerations for outcomes in clinical research: A review of common data types and methodology

Sources of preanalytical error in pharmacokinetic analyses – focus on intravenous drug administration and collection of blood samples

Population Pharmacokinetics - A Regulatory Perspective

New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

Some Statistical Issues of Confirming Efficacy in Clinical Trials

Modeling Biphasic, Non-Sigmoidal Dose-Response Relationships: Comparison of Brain-Cousens and Cedergreen Models for a Biochemical Dataset

Reliability of Pharmacodynamic Analysis by Logistic Regression

Clinician's Approach to Advanced Statistical Methods: Win Ratios, Restricted Mean Survival Time, Responder Analyses, and Standardized Mean Differences

Statistical Applications in Pharmaceutical Product Development: A Comprehensive Review

ISSUES IN BIOMEDICAL STATISTICS: COMPARING MEANS UNDER NORMAL DISTRIBUTION THEORY

The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development

Using confidence interval method to assess linear pharmacokinetics in dose escalation study

Strategies to mitigate bias from time recording errors in pharmacokinetic studies

Common mistakes in biostatistics

Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods